{
  "id": "mhgap#screening_cues_ef46ec4e",
  "content": "doses should be tapered off slowly. Any withdrawal\nResearch gaps symptoms should be closely monitored.\ny Most of the research is from HICs. Further research is y Providers should keep in mind the possible adverse\nneeded in LMICs. effects associated with antidepressants, the ability\ny More research is needed to investigate the to deliver either intervention (in terms of expertise,\nrelationship between the number of depressive and/or treatment availability) and individual\nepisodes and optimal treatment duration. preferences. Discontinuities in drug availability\ny More research is needed to examine the evidence (common in LMICs) may interfere with continuation\nto evaluate adverse effects regarding the duration of treatment.\nof treatment. y Costs accumulate with duration of prescription.\ny Further research is needed on how best to support Cost of daily dose of generic antidepressants varies\nindividuals in managing withdrawal symptoms when from region to region throughout the world ranging\nstopping antidepressant medicines and guidance between 3% and 9% of minimum wage (131).\nfor clinicians on tapering of antidepressants and\nmanagement of withdrawal symptoms.\n60\n3. Recommendations\nDEP3. Is brief, structured psychological treatment better than (more\neffective than/as safe as) treatment as usual in adults with\ndepressive episode/disorder?",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "relationships",
      "screening_cues",
      "referral",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Screening Cues doses should be tapered off slowly. Any withdrawal\nResearch gaps symptoms should be closely monitored.\ny Most of the research is from HICs. Further research is y Providers should keep in mind the possible adverse\nneeded in LMICs. effects associated with antidepressants, the ability\ny More research is needed to investigate the to deliver either intervention (in terms of expertise,\nrelationship between the number of depressive and/or treatment availability) and individual\nepisodes and optimal treatment duration. preferences. Discontinuities in drug availability\ny More research is needed to examine the evidence (common in LMICs) may interfere with continuation\nto evaluate adverse effects regarding the duration of treatment.\nof treatment. y Costs accumulate with duration of prescription.\ny Further research is needed on how best to support Cost of daily dose of generic antidepressants varies\nindividuals in managing withdrawal symptoms when from region to region throughout the world ranging\nstopping antidepressant medicines and guidance between 3% and 9% of minimum wage (131).\nfor clinicians on tapering of antidepressants and\nmanagement of withdrawal symptoms.\n60\n3. Recommendations\nDEP3. Is brief, structured psychological treatment better than (more\neffective than/as safe as) treatment as usual in adults with\ndepressive episode/disorder? Doses should be tapered off slowly. any withdrawal\nresearch gaps symptoms should be closely monitored."
}